Adhera Therapeutics, Inc. (ATRX) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Baton Rouge, LA, 미국. 현재 CEO는 Andrew Albert Kucharchuk.
ATRX 을(를) 보유 IPO 날짜 1993-12-07, 2 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $722.00.
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
